Surgery for Intravenous Leiomyomatosis (SIVL)
This study has been completed.
Information provided by (Responsible Party):
Li Yang, General Hospital of Beijing PLA Military Region
First received: October 14, 2012
Last updated: October 15, 2012
Last verified: October 2012
Intravenous leiomyomatosis (IVL) with intracardiac extension is a rare benign smooth muscle tumor. Reviewing literature, intracardiac extension of the IVL has been reported in at least 70 cases. Most are individual case reports. Surgical experience is not much. However, different opinion of surgical strategies remain controversial. The purpose of this report is to describe our experience of surgical management for the IVL with intracardiac extension.
||Observational Model: Cohort
Time Perspective: Retrospective
||Surgical Management of Intravenous Leiomyomatosis With Intracardiac Extension: Our Experience and Outcomes
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||April 2012 (Final data collection date for primary outcome measure)
All patients underwent surgical management. Clinical data were obtained from medical reports. Following-up was made through email and telephone.
|Ages Eligible for Study:
||18 Years to 80 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
From March 1997 to June 2011, 6 women patients were admitted to our hospital with intravenous leiomyomatosis with intracardiac extension.
- Age more than 18 years.
- Tumor markers were all within normal limits.
- Patients underwent surgical management.
- Patients were followed-up for more than 12 months.
-Tumor markers were all within abnormal limits
Please refer to this study by its ClinicalTrials.gov identifier: NCT01707862
|Institute of Cardiovascular Disease
|Beijing, China |
||Genetal Hospital Beijing Military Region, First class
||Institute of Cardiovascular Disease
No publications provided
||Li Yang, Doctor, General Hospital of Beijing PLA Military Region
History of Changes
|Other Study ID Numbers:
|Study First Received:
||October 14, 2012
||October 15, 2012
||China: Food and Drug Administration
Keywords provided by General Hospital of Beijing PLA Military Region:
Smooth muscle tumor
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on May 23, 2013
Neoplasms, Muscle Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type